ACCENTIA BIOPHARMACEUTICALS INC·4

Jun 23, 2:37 PM ET

RYLL TIMOTHY D 4

4 · ACCENTIA BIOPHARMACEUTICALS INC · Filed Jun 23, 2006

Insider Transaction Report

Form 4
Period: 2006-04-03
Transactions
  • Other

    Common Stock

    2006-04-03$8.00/sh+5,339$42,7123,634,160 total(indirect: By MOAB INVESTMENT, LP)
Footnotes (2)
  • [F1]Represents the receipt of shares of common stock in lieu of accrued but unpaid dividends on the Company's former Series E Convertible Preferred Stock at a price of $8.00 a share.
  • [F2]Mr. Ryll is the sole shareholder and sole director of MOAB Management Company, Inc., which is the sole general partner of MOAB Investments, LP. Mr. Ryll disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    rrd121970.xmlPrimary

    FORM 4